The predictive value of the CA-125 modeled kinetic parameter KELIM is validated in 3 independent datasets (AGO-OVAR 7 & 9; ICON 7 AGO/GINECO/GCIG trials).

Authors B.M. You O. Colomban M. Tod I.L. Ray-Coquard A. Lortholary A.C. Hardy-Bessard A. Du Bois J. Huober W. Meier C. Kurzeder
Journal Annals of Oncology, Volume 27, Issue suppl_6, 1 October 2016, 857PD Lien

Two prognostic populations of ovarian cancer patients defined by CA-125 modeled kinetic parameter KELIM (AGO-OVAR 7 & 9; ICON 7 AGO/GINECO/ MRC CTU/GCIG trials).

Authors Benoit You, Olivier Colomban, Gilles Freyer, Alexandra Leary, Isabelle Laure Ray-Coquard, Alain Lortholary, Anne Claire Hardy Bessard, Jacobus Pfisterer, Andreas Du Bois, Christian Kurzeder, Alexander Burges, and Michel Tod
Journal Journal of Clinical Oncology 2017 35:15_suppl, 5554-5554

Early prediction of treatment resistance in low-risk gestational trophoblastic neoplasia using population kinetic modelling of hCG measurements.

Authors You B, Harvey R, Henin E, Mitchell H, Golfier F, Savage PM, Tod M, Wilbaux M, Freyer G, Seckl MJ.
Journal Br J Cancer. 2013 May 14;108(9):1810-6. PubMed PMID: 23591194

Predictive values of hCG clearance for risk of methotrexate resistance in low-risk gestational trophoblastic neoplasias.

Authors You B, Pollet-Villard M, Fronton L, Labrousse C, Schott AM, Hajri T, Girard P, Freyer G, Tod M, Tranchand B, Colomban O, Ribba B, Raudrant D, Massardier J, Chabaud S, Golfier F.
Journal Ann Oncol. 2010 Aug;21(8):1643-50. PubMed PMID: 20154304

Prognostic value of modeled PSA clearance on biochemical relapse free survival after radical prostatectomy.

Authors You B, Girard P, Paparel P, Freyer G, Ruffion A, Charrié A, Hénin E, Tod M, Perrin P.
Journal Prostate. 2009 Sep 1;69(12):1325-33. PubMed PMID: 19475643

A critical review of the analytical approaches for circulating tumor biomarker kinetics during treatment.

Authors You B, Almufti R, Wilbaux M, Oza A, Henin E, Freyer G, Tod M, Colomban O
Journal Annals of Oncology 25: 41–56, 2014 PubMed PMID: 24356619